Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Main Inclusion Criteria:

- General good health, other than perennial allergic rhinitis

- History and diagnosis of perennial allergic rhinitis by skin prick test

- Parent/caregiver must be capable of understanding the requirements, risks, and
benefits of study participation, and, as judged by the investigator, capable of
giving informed consent and comply with all study requirements (visits,
record-keeping, etc.)

Main Exclusion Criteria:

- Participation in any investigational drug trial within the 30 days preceding the
Screening Visit or at any time during the trial

- Use of any prohibited concomitant medications as defined by the study protocol

- Non-vaccinated exposure to, or active infection with, chickenpox or measles within
the 21 days preceding the Screening Visit